Skip to main content

Research summary

Research Hub

N-Acetyl Epitalon Amidate

Clinical10 studies

N-Acetyl Epitalon Amidate is a modified Epitalon analogue explored in peptide stability and longevity research models.

Being studied for

  • Peptide stability research
  • Cellular aging mechanisms

Published Research

Evidence profile

Controlled human evidence

10 cited publications · 1 primary trial

Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.

Supporting evidence

ClinicalPrimary trial

Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa

Khavinson V et al. · Neuro endocrinology letters · 2002

The study reportedEpitalon therapy in patients with degenerative retinal lesions results in a positive clinical effect in 90% of the cases. The analysis of Epitalon effects suggests that the tetrapeptide participates in the mechanisms of transcription common for the epiphysis and retina.

PMID 12195242View on PubMed
Additional indexed literature (9)

Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Cobalt Peptides material. Citations verified against PubMed on 2026-08-09.

Notice

All information on this page is provided strictly for laboratory research and educational purposes only.